1 Min Read
Jan 31 (Reuters) - Strides Shasun Ltd:
* PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT BANGALORE; WILL BE MARKETED BY STRIDES PHARMA IN U.S. MARKET Source text - bit.ly/2EqTVGU Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.